NeoALTTO trial indicates breast cancer patients who had pathologic complete response had improved event-free and overall survival

Immune cells in tumours may identify breast cancer patients most likely to benefit from trastuzumab

BETH study: highly effective treatment option for patients with HER2 breast cancer

Screening mammography, over diagnosis and over treatment

Initial phase III results of the first trial in newly diagnosed multiple myeloma

Effective treatment of chemotherapy-refractory diffuse large B cell lymphoma

Toxicity complications from chemotherapy in lung cancer treatment

Multidisciplinary in cancer care in India

Cancer cells and the immune system: a natural story?

Immuno-Oncology: the next new paradigm in cancer treatment? Chairman's welcome and introduction

Immuno-Oncology: a concept or already a reality?

Cancer staging as a form of control